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 ABSTRACT 
Metal implants are widely used to provide structural support and stability in current 
surgical treatments for bone fractures, spinal fusions, and joint arthroplasties as well as 
craniofacial and dental applications. Early implant-bone mechanical fixation is an important 
requirement for the successful performance of such implants. However, adequate 
osseointegration has been difficult to achieve especially in challenging disease states like 
osteoporosis due to reduced bone mass and strength. Here, we present a simple coating strategy 
based on passive adsorption of FN7-10, a recombinant fragment of human fibronectin 
encompassing the major cell adhesive, integrin-binding site, onto 316-grade stainless steel (SS). 
FN7-10 coating on SS surfaces promoted α5β1 integrin-dependent adhesion and osteogenic 
differentiation of human mesenchymal stem cells. FN7-10-coated SS screws increased bone-
implant mechanical fixation compared to uncoated screws by 30% and 45% at 1 and 3 months, 
respectively, in healthy rats. Importantly, FN7-10 coating significantly enhanced bone-screw 
fixation by 57% and 32% at 1 and 3 months, respectively, and bone-implant ingrowth by 30% at 
3 months compared to uncoated screws in osteoporotic rats. These coatings are easy to apply 
intra-operatively, even to implants with complex geometries and structures, facilitating the 
potential for rapid translation to clinical settings. 
 
 INTRODUCTION 
Metal implants are widely used in current surgical treatments for bone fractures, spinal 
fusions, and joint arthroplasties as well as craniofacial and dental applications. In particular, 
stainless steel (SS) plates, screws and pins are extensively used as bone fracture fixation devices 
due their mechanical properties, corrosion resistance and cost effectiveness when compared to 
other metallic implants [1, 2]. For example, stainless steel has improved shear strength compared 
to titanium. SS fracture fixation devices are conventional treatments for fractures in osteoporotic 
patients, which accounted for >2 million fractures in the USA at a cost of an estimated $19B [1]. 
The major problem in the management of osteoporotic fractures, which are characterized by poor 
bone stock with decreased implant pull-out strength, is unstable fixation arising from screw 
loosening and cutout, with rates ranging from 5-23% [3-5]. Similarly, transpedicular screw 
fixation represents the gold standard in the treatment of spinal deformities, spondylolisthesis, 
traumatic fractures, and reconstructions after spinal tumor resection [6, 7]. Furthermore, metal 
instrumentation is increasingly used in spinal fusions to improve stability and enhance fusion 
rates [6, 8]. Pedicle screw loosening represents a major complication of these spinal fixation 
procedures. Studies with well-defined radiological criteria documented high (18-27%) loosening 
rates [9-11]. In addition to contributing to instrumentation breakage and failure (11% incidence 
[12]), screw loosening results in pain, loss of spinal alignment, and increased incidence of 
pseudoarthrosis [9, 13]. Screw loosening has a significant higher incidence in fixation of 
vertebral bodies with low mineral density or in patients with osteoporosis, neuromuscular 
disorders, or post-radiation therapy [14, 15]. 
Various strategies have been explored to enhance osseointegration of metal implants [16-
21]. Surface roughness has been shown to increase osteoblast differentiation and mineralization 
[18, 22]. Additionally, increased surface roughness results in production of phospholipase A2 in 
osteoblasts which then catalyzes prostaglandin E2 and makes osteoblasts responsive to systemic 
hormones such as 1,25-(OH)2D3 [16]. Hydrofluoric acid-etched titanium implants exhibited 
significantly higher bone-implant contact compared to non-treated implants in rat tibiae [23]. 
Similarly, acid etched screws implanted in rabbit distal femurs had enhanced osseointegration 
compared to machined screws [18]. In contrast, Kang et al. implanted SS mini screws that were 
either machined or laser-surface treated in the maxilla of dogs and found no improvements in 
bone-implant contact [24]. Similarly, rough and smooth SS pegs implanted in the distal femur of 
rabbits showed no differences in osseointegration [25]. These studies highlight the difficulties in 
identifying surface roughness/topography parameters needed for enhanced osseointegration [26]. 
Reproducible surface roughness is difficult to produce due to use of different instruments and 
techniques, as well as complex geometries associated with dental and orthopaedic devices, and 
hence there is wide inconsistency across published studies [26, 27]. Hydroxyapatite (HA) and 
other calcium phosphate (CaP) coatings applied to implant surfaces have also been shown to 
promote osseointegration [28-31]. HA-coated implants bridge 1-2 mm gaps between implant and 
bone and had higher bone in-growth compared to uncoated implants when implanted in femoral 
condyles of dogs [19]. Titanium implants with CaP coatings showed significantly higher bone 
contact in goat femoral diaphysis compared to uncoated implants at 6-, 12- and 24-weeks [32]. 
However, such coatings are often mechanically unstable and difficult to apply uniformly on 
implants with complex shapes, thereby limiting their use [33, 34].  Bisphosphonates have been 
proposed to enhance osseointegration of implants in healthy and osteoporotic bone [35-40]. 
Bisphosphonates reduce early stage resorption of bone caused by surgical and implantation 
trauma by inhibiting osteoclasts [36]. Bisphosphonate coatings on dental titanium implants in 
human maxilla result in improved fixation [41]. These coating procedures, however, are fairly 
complex and require chemical modification of implants [35, 37, 41]. Furthermore, systemic use 
of bisphosphonates has been linked to higher risk of atypical femoral fractures in women [42] 
raising safety concerns.   
Despite this progress, there is still a significant and unmet need to improve the integration 
of metal implants and bone, especially in clinically challenging scenarios such as osteoporosis 
due to low bone mass density and strength [43, 44]. To enhance implant-bone integration, 
presentation of adhesion motifs from extracellular matrix proteins that bind integrin adhesion 
receptors on implant surfaces has been proposed [45-53]. We previously showed that 
presentation of a recombinant fragment spanning the 7-10th type III repeats of human fibronectin 
(FN7-10), which contains the integrin-binding RGD site in the 10th type III repeat and PHSRN 
synergy site in the 9th type III repeat, on titanium implants improved bone-implant contact and 
mechanical fixation in healthy rats [51, 53]. However, the efficacy of integrin-specific coatings 
on improving osseointegration in disease models such as osteoporosis has not been tested. The 
objectives of this study were to apply FN7-10 coatings by a simple one-step passive adsorption 
onto clinical grade SS implant and evaluate the effects of these coatings on implant 
osseointegration in healthy and osteoporotic rats. 
 
METHODS  
Recombinant FN7-10 production 
FN7-10 was expressed in E. coli and purified as previously described [54]. Briefly, 
JM109 bacterial cells containing the FN7-10 construct were streaked onto lysogeny broth (LB) 
agar plates containing 100 mg/mL ampicillin and incubated overnight. Colonies were isolated 
and dynamically cultured in LB broth (100 mg/mL ampicillin; 2 mM d-biotin). At 6 h, 100 mM 
isopropylthio-β-galactoside (IPTG) was added to augment protein production. The culture was 
spun down at 4000g for 10 min at 4 oC, and the cell pellet was lysed using bacterial protein 
extraction reagent (B-PerTM, Life Technologies, Carlsbad, CA, USA). The lysate was centrifuged 
(10,000g) for 20 min. The protein supernatant was sterile-filtered, and purified by affinity 
chromatography using a 5 mL column of Ultralink Immobilized Monomeric Avidin (Life 
Technologies) and eluted using d-biotin. After removing d-biotin using 30 kDa Microcon 
centrifugal filter devices (Millipore, Billerica, MA, USA), protein fractions were sterile-filtered. 
Purified protein was verified by Western blotting and enzyme-linked immunosorbent assay 
(ELISA), and endotoxin levels were below the recommended maximum FDA level (0.5 EU/ml) 
as determined by the Limulus Amebocyte Lysate (LAL) chromogenic assay. 
SS samples and coating 
SS plates (25 mm x 25 mm x 0.5 mm) were purchased from Goodfellow (Coraopolis, PA, 
USA). Surfaces were cleaned in Piranha solution for 30 min and sterilized by autoclaving. FN7-
10 coatings were generated by incubating SS samples in purified solutions of FN7-10 in PBS for 
30 min at room temperature. The density of adsorbed FN7-10 was quantified by ELISA [55]. 
Briefly, SS samples were incubated in varying concentrations of FN7-10 and washed multiple 
times with 0.05% v/v Triton-X-100 in PBS. Samples were then incubated in 1% w/v casein 
blocker (Life Technologies) and probed with 1 µg/mL HFN7.1 antibody (Developmental 
Hybridoma Studies Bank, Iowa City, Iowa, USA). HFN 7.1 binds between the  9th and 10th type 
III repeat of fibronectin and blocks cell adhesion to the central integrin-binding site [55]. After 
several washes, samples were incubated in alkaline phosphatase (ALP)-conjugated antibody (1 
µg/mL). Following several washes, samples were incubated with 5-methyl umbelliferyl 
phosphate substrate (60 µg/mL) and fluorescence read at excitation/emission of 360 nm/465 nm 
on a HTS 7000 Plus plate reader (Perkin Elmer, Akron, Ohio, USA). Absolute values of 
adsorbed FN7-10 were determined by comparing fluorescence readings to reference titanium 
samples coated with FN7-10 [53].  For cell experiments, SS samples were coated with 50 µg/mL 
FN7-10 for 30 min to generate a saturated FN7-10 monolayer. 
Cell adhesion and osteoblastic differentiation 
Human mesenchymal stem cells (hMSCs) were obtained from the Institute of 
Regenerative Medicine at Texas A&M (College Station, TX, USA) cultured in Lonza 
mesenchymal stem cell medium (MSCM) and SingleQuots, and passaged every 3 to 4 days. 
hMSCs were seeded on SS samples that were either coated with FN7-10 or incubated in PBS 
(uncoated) in a 12-well plate. Each SS sample was seeded with 10,000 cells. Cells were allowed 
to adhere in 10% v/v serum-containing media for 2 h at 37º C and 5% v/v CO2. Samples were 
then washed with PBS, incubated in Calcein-AM (1 µg/mL, Life Technologies) to label live 
cells, and imaged using an upright fluorescent microscope. Five random images were taken per 
sample and analyzed for total cells and cell spread area using ImageJ software. For integrin 
blocking experiments, cells were labeled with Calcein-AM (1 µg/mL) for 15 min, incubated in 
the presence of 10 µg/mL anti-integrin α5 (BIIG2, Developmental Studies Hybridoma Bank), 10 
µg/mL anti-integrin αvβ3 (clone LM609, Millipore) or corresponding isotype control antibodies 
for 10 min prior to cell seeding, and seeded for 1 h in serum-containing media with 50,000 cells 
per sample. This time point was chosen to minimize antibody internalization. SS samples were 
then washed 3 times with PBS to remove poorly adherent cells and imaged using an upright 
fluorescence microscope. 
For osteoblastic differentiation assays, hMSCs were plated at 10,000 cells/cm2 onto FN7-
10-coated and control uncoated SS samples in osteogenic differentiation media from Lonza 
(Allendale, NJ, USA). Alkaline phosphatase (ALP) activity was quantified at 9 days in culture 
[50]. Briefly, a probe sonicator was used to lyse cells, and equal protein amounts were added to 
5-methyl umbelliferyl phosphate substrate (60 µg/mL) for 60 min. Fluorescence was measured 
(360 nm/465 nm) and enzymatic activity normalized to total amount of protein. Alizarin red 
staining was used to quantify mineralization [56]. hMSCs were cultured for 21 days on SS 
samples in osteogenic media. Cells were then fixed with 3.7% w/v formaldehyde for 20 min and 
stained with 40 mM Alizarin red (pH 4.1) for 20 min at room temperature. Samples were washed 
with water and incubated with 10% v/v acetic acid for 30 min. Stained surfaces were then 
scraped and transferred in a tube and heated at 85oC for 10 min. Resulting slurry was centrifuged 
at 18,000g for 10 minutes and supernatant was neutralized with 10% w/v ammonium hydroxide. 
Absorbance readings were taken at 405 nm.  
Screw implantation 
All experiments were conducted in accordance with an Institutional Animal Care and Use 
Committee (IACUC)-approved protocol. Female, 8-10 weeks old Sprague-Dawley rats were 
purchased from Harlan (Dublin, VA, USA) and used in two studies. For Study 1, healthy rats 
were used at the age of 10-12 weeks at the time of surgery. For Study 2, ovariectomized (OVX) 
or sham-operated animals (surgically operated similar to OVX rats except that the ovaries were 
not cauterized) were used three months after ovariectomy (age of 25-27 weeks at the time of 
surgery). Because ovariectomized rats have increased appetites and gain weight, animals were 
pair-fed daily to eliminate weight gain as a confounding variable [57]. The amount of food given 
to ovariectomized animals was similar to that consumed by sham-operated controls. The 
osteoporotic state in ovariectomized subjects was confirmed by micro-computed tomography 
(µCT) imaging of the proximal tibia [58]. For µCT scanning, a 3.125 mm length of that proximal 
tibia was scanned in anesthetized, live rats on the right leg using a VivaCT system (Scanco 
Medical, Wayne, PA, USA; 145 mA intensity, 55 kVp energy, 376 ms integration time, and 12.5 
µm resolution). Bone structure was evaluated by contouring 2D slices to include only the 
trabecular bone. 3D µCT reconstructions were rendered and the ratio of bone volume to total 
volume was computed as a measure of osteoporotic state in ovariectomized rats with sham-
operated animals as controls. 
 SS 316 grade M2 screws (McMaster Carr, Atlanta, GA, USA) (2.0 mm in thread length, 
2 mm thread diameter) were cleaned with Piranha solution for 30 min and sterilized by 
autoclaving. Screws were then incubated in 50 µg/mL FN7-10 or PBS for 30 min at the time of 
surgery. For implantation, the proximal tibia was exposed by a 1.5 cm longitudinal incision 
through the skin. Muscle was separated using blunt dissection. Using a 1.7 mm diameter drill bit, 
a hole was made approximately 2-5 mm distal from the tibial metaphysis. Implants were screwed 
into the hole, muscle sutured and the skin closed via wound clips. Each rat received one screw 
per tibia (two per rat) with each animal receiving uncoated and FN7-10-coated screws with 
implant coating group randomized between left and right leg. A dose of sustained-release 
buprenorphine was administered immediately after anesthesia induction. The rats were allowed 
to bear weight immediately after surgery without any restrictions. 
Osseointegration analysis 
Animals were euthanized at either 4 or 12 weeks post-implantation, and tibiae harvested. 
Samples were either fixed in neutral-buffered formalin for histology or wrapped in PBS-soaked 
gauze to maintain moisture for immediate mechanical testing. For sectioning, explanted tibiae 
were fixed in neutral-buffered formalin and processed through ascending grades of ethanol 
followed by xylene before embedding in methyl methacrylate. After embedding, rough sections 
were cut (Isomet® 1000 Precision Saw, Buehler, Lake Bluff, IL, USA) and ground to 50 µm 
(EXAKT 400 CS). Sections were stained using Sanderson’s Rapid Bone Stain with a Van 
Gieson’s counterstain to distinguish mineralized tissue (red) from other soft tissues. Images were 
taken using a Nikon Eclipse E600 and the fraction of area staining for bone within the screw 
thread was measured using ImageJ (NIH, Bethesda, MD, USA).  
Pull-out testing was performed to quantify implant mechanical fixation to surrounding 
bone tissue using a MTS 858 Mini Bionix II (MTS Systems, Eden Prairie, MN, USA). The 
explanted tibia was secured using a customized holding apparatus, and the exposed head of the 
implant attached to a load cell via piano wire using a customized grip apparatus. Pre-loaded 
samples (1.0 N) were then subjected to a constant loading rate of 0.2 N/sec. The pull-out force 
(N), parallel to the long axis of implant, was the maximum load achieved before implant 
detachment or failure. 
Statistics 
Results are presented as mean and standard deviation. Results were analyzed by one-
tailed Student’s t-test in GraphPad and a confidence level of 95% was considered significant. All 
assays (except mechanical testing) were conducted at least in triplicate. 
 
RESULTS 
Passive adsorption of FN7-10 onto SS 
Recombinant FN7-10 protein was produced with high purity (>95%) and biological 
activity as determined by gel staining, Western blotting, and ELISA using the HFN7.1 receptor-
mimetic antibody, in excellent agreement with previous reports [51, 53, 54]. We examined the 
adsorption of FN7-10 onto SS from a pure FN7-10 solution using a modified ELISA. Passive 
adsorption of FN7-10 onto SS surfaces is expected to be driven by entropic displacement of 
water (hydrophobic interactions) and other non-covalent interactions (hydrogen bonding, 
electrostatic, etc). The adsorption profile for FN7-10 onto SS exhibited a hyperbolic dependence 
on FN7-10 coating concentration, with linear increases at low FN7-10 concentrations and 
reaching saturated levels at around 30 µg/mL (Fig. 1). A coating concentration of 50 µg/mL was 
selected for all subsequent experiments which resulted in a surface density of 56.1 ± 5.3 ng/cm2 
(1.1 ± 0.10 pmol/cm2). The adsorption profile for SS shown in Figure 1 is consistent with that of 
titanium previously reported [53]. At a coating concentration of 50 µg/mL, FN7-10 surface 
density is similar for both surfaces: 1.1 ± 0.1 pmol/cm2 for SS vs 1.4 ± 0.2 pmol/cm2 for 
titanium.  
FN7-10 coating promotes hMSC cell adhesion and osteoblastic differentiation 
hMSCs were cultured on FN7-10-coated and uncoated SS surfaces in serum-containing 
media. hMSCs express high levels of several fibronectin-binding integrins including α5β1 [59]. 
Cells cultured on FN7-10-coated SS surfaces had higher adhesion levels at 1 h compared to 
uncoated surfaces (Fig. 2). Cell adhesion density was two-fold higher on FN7-10-coated SS 
compared to uncoated SS (Fig. 2C) (p<0.002). Cells on FN7-10-coated SS also had higher 
spread area than cells on uncoated SS (Fig. 2D) (p<0.03). Blocking studies with integrin-specific 
antibodies demonstrated that hMSCs primarily adhere to FN7-10-coated SS via the α5β1 integrin 
(p<0.0001) (Fig. 3A). In contrast, hMSC adhesion to uncoated SS was not blocked by α5β1-
blocking antibodies (Fig. 3B). Cell adhesion to uncoated SS most likely involves integrin 
binding to adsorbed serum proteins such as vitronectin that bind αV integrins. An αVβ3-blocking 
antibody partially reduced hMSC adhesion to uncoated SS compared to the isotype control 
(p<0.05). These results demonstrate that hMSC interact with FN7-10-coated SS primarily via 
α5β1 integrin, whereas cells adhere to uncoated SS using different integrins, including αVβ3. 
Binding of α5β1 to fibronectin in hMSCs promotes differentiation towards the osteogenic 
lineage [59, 60]. To evaluate the effect of FN7-10-coated SS on osteoblastic differentiation, we 
cultured hMSCs on SS in osteogenic media for 9 days after which the cells were lysed and 
quantified for ALP activity, an early marker for osteogenic differentiation [61]. Cells cultured on 
FN7-10-coated SS had 3-fold higher levels of ALP activity compared to cells on uncoated 
surfaces (Fig. 4A) (p<0.006).  We also examined matrix mineralization via Alizarin red staining 
as a mature marker of osteoblastic differerentiation [56]. Consistent with ALP activity results, 
hMSCs cultured on FN7-10-coated surfaces exhibited significantly higher mineralization than 
cells cultured on uncoated SS at 21 days (Fig. 4B) (p<0.02).  
FN7-10 coating enhances SS implant osseointegration in healthy rats 
 We previously showed that FN7-10 coatings enhance bone-implant contact and 
mechanical fixation of commercially pure, machine-finished titanium rods in healthy rats [53]. In 
the current study, we first evaluated the effect of FN7-10 coating on the osseointegration of SS 
screws implanted in the tibiae of healthy rats. SS screws were coated with FN7-10 by simply 
incubating in FN7-10 solution for 30 min prior to surgery, and one screw was implanted in the 
tibial metaphysis of each leg. At 1 and 3 months after the implantation, rats were euthanized and 
implant-bone pull-out force was measured. FN7-10-coated SS screws exhibited 30% higher pull-
out force than uncoated screws at 1 month of implantation (p<0.01) (Fig. 5A). Similarly, FN7-10 
coating enhanced the mechanical fixation of SS screws to bone at 3 months by 45% compared to 
uncoated screws (p<0.03) (Fig. 5B).  
FN7-10 coating enhances osseointegration of SS screws in osteoporotic rats 
 Osteoporosis leads to destruction of bone microstructure and trabecular bone [62], and 
these reductions in bone mass lead to increased risk for fractures. Importantly, loss of bone mass 
results in weak osseointegration of implants [43, 44]. To test whether FN7-10 coating on SS 
enhances implant osseointegration in this challenging diseased state, we used ovariectomized rats 
as a model of osteoporosis [63]. To confirm osteoporosis, live animal µCT was performed 3 
months after ovariectomy. The ratio of bone volume to total volume (BV/TV) in the tibial 
metaphysis was calculated for ovariectomized and sham-operated control rats. µCT analyses 
demonstrated significant reductions in the trabecular bone volume fraction of ovariectomized 
rats (BV/TV: 0.09±0.03) compared to sham-operated rats (BV/TV: 0.33±0.07) (p < 0.001) (Fig. 
6).  
Following confirmation of osteoporosis, we implanted FN7-10-coated and uncoated SS 
screws in both osteoporotic and sham-operated rats. For both osteoporotic and sham-operated 
rats, FN7-10-coated SS screws exhibited significantly higher mechanical fixation at 1 and 3 
months post-implantation compared to uncoated screws (Fig. 7). Importantly, FN7-10 coatings 
enhanced SS screw-bone pull-out force by 57% (p<0.03) and 32% (p<0.05) over uncoated 
screws in osteoporotic rats at 1 and 3 months, respectively (Fig. 7A). The observed increases in 
pull-out force for FN7-10-coated screws compared to uncoated screws for sham-operated 
controls (Fig. 7B) are consistent with the enhancements in mechanical fixation in naïve, healthy 
rats (Fig. 5). Taken together, these results demonstrate that FN7-10 coatings applied to SS 
screws significantly enhance bone-implant mechanical fixation in both healthy and osteoporotic 
rats. 
Histological sections were also generated and stained to evaluate bone-metal contact and 
bone ingrowth into thread regions at the interface of screw and bone for osteoporotic rats.  
Overall, SS screws were well tolerated and remained in close apposition to the cortical bone for 
all groups. No evidence of foreign body giant cells or fibrous capsule was observed in any of the 
histological sections. We performed histomorphometric analyses to quantify bone ingrowth into 
the screw threads. Consistent with the enhancements in screw mechanical fixation, a 30% 
increase in bone ingrowth was observed for FN7-10-coated screws compared to uncoated screws 
(p<0.003) (Fig. 8).  
 
DISCUSSION 
In the present study, we show that simple adsorption of the recombinant fibronectin 
fragment FN7-10 onto SS significantly enhances hMSC adhesion and osteoblastic 
differentiation. Importantly, this simple coating process also enhances the mechanical fixation 
and bone-implant contact of SS screws in healthy and osteoporotic rats. Blocking studies with 
integrin-specific antibodies demonstrated that hMSCs primarily adhere to FN7-10-coated SS via 
the α5β1 integrin, whereas cells adhere to uncoated SS using different integrins, including αVβ3. 
We previously showed that integrin binding specificity and signaling via α5β1 integrin regulates 
osteoblastic differentiation and osseointegration of smooth titanium implants [51, 64]. An 
important aspect of the present study is that these integrin-specific coatings were generated by 
simple passive adsorption (30 min) from solution. This facile coating strategy can be easily 
applied to metal implants and devices with complex geometries and structures. Additionally, the 
coating can be simply applied to any device at the time of surgery in a point-of-care application. 
Such simple application contrasts with other coating strategies focused on calcium-phosphate 
ceramics and polymers for drug delivery which require direct modification of the device prior to 
surgery, challenges with manufacturing, processing and sterilization, particularly for complex 
geometrical shapes and structures, and potential batch-to-batch variability [30]. For instance, 
calcium-phosphate coatings are applied using techniques such as pulsed laser deposition, sputter 
deposition, and ion beam deposition which lead to non-uniform deposition on screws [33]. 
Although the initial FN7-10 surface density can be easily controlled (Fig. 1), it is unlikely that 
FN7-10 will remain on the implant surface long-term. However, we expect that cells at the 
implant interface remodel the coating and deposit matrix that promotes bone formation and 
integration. As such, we hypothesize that this cell adhesive coating initiates pro-healing 
responses at the surface of the implant that result in enhanced implant-bone integration.  
The major contribution of this study is the successful application of this simple coating 
strategy to improve implant osseointegration in a model of osteoporosis. This is a highly 
significant finding as the previous work using passive adsorption of ECM proteins has been done 
only with healthy subjects and demonstrating that this simple strategy is effective in a diseased 
state has considerable impact. Notably, the present study is the first report showing that an 
adhesive peptide-based strategy enhances SS implant osseointegration in an osteoporotic model. 
CaP and bisphosphonate coatings have shown improved osseointegration in osteoporotic bone 
[65], however simple passive adsorption of FN7-10 has significant advantages over complex 
coating strategies utilized for calcium phosphate-based and bisphosphonate coatings. 
The main objective of the present study was to examine whether this simple, integrin-
specific coating enhances bone-implant integration in conditions where the bone is compromised 
such as osteoporosis. The most significant problem in the management of osteoporotic fractures, 
which are characterized by poor bone stock with decreased implant pull-out strength, is unstable 
fixation arising from screw loosening [3-5]. Similarly, pedicle screw loosening represents a 
major complication of spinal fixation procedures, particularly in osteoporotic patients [66, 67]. 
We show that simple adsorption of FN7-10 on 316-grade SS leads to significant enhancements in 
mechanical fixation to bone at early (1 month) and late time points (3 month). Furthermore, 
FN7-10 coatings increased bone ingrowth into the screw threads compared to untreated screws. 
Future studies on large animals are necessary to establish the potential of this simple coating 
strategy for use in clinical settings. 
We note that the pull-out force for uncoated and FN7-10-coated screws for sham-
operated rats was less than healthy rats at 1 month implantation. However, by the end of 3 month 
time point, the pull-out forces were equivalent. We attribute the differences at the early time 
point to age differences at the time of screw implantation as sham-operated rats were 6-7 months 
old while healthy rats were 3 months old. It has been previously shown that aged rodents have 
reduced healing response to bone fractures compared to young healthy rodents [68]. 
Additionally, for osteoporotic rats, pull-out forces were consistently lower compared to sham-
operated and healthy rats at both 1 and 3 month time points. Although FN7-10 coatings led to 
significant enhancement in pull-out forces in osteoporotic rats, the resulting forces were 25% 
lower than those for sham-operated rats. This difference in pull-out forces reflects the poor 
mechanical properties and limited osseointegrative potential of osteoporotic bone.  
 
CONCLUSION 
We demonstrate that simple adsorption of the recombinant fibronectin fragment FN7-10 
onto SS promotes α5β1 integrin-dependent adhesion and osteogenic differentiation of hMSCs. 
Importantly, FN7-10-coated SS screws significantly enhanced bone-implant mechanical fixation 
and bone contact in both healthy and osteoporotic rats. These coatings are easy to apply intra-
operatively, even to implants with complex geometries and structures, facilitating the potential 
for rapid translation to clinical settings. 
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 Figure Captions: 
Figure 1: FN7-10 adsorption onto SS coupons as a function of FN7-10 coating concentration. 
Hyperbolic curve-fit (ads density = 78.8 * conc/[17.9 + conc], R2 = 0.98) shown. 
 
Figure 2: FN7-10 coating enhances cell adhesion and spreading on SS. Fluorescence microscopy 
images of hMSCs stained with calcein and cultured on (A) uncoated SS and (B) FN7-10-coated 
SS. Quantification of (C) adherent cell density and (D) cell spreading area for hMSCs cultured 
on FN7-10-coated and uncoated surfaces.  
 
Figure 3: Blocking studies with integrin-specific antibodies. Adherent cell density on (A) FN7-
10-coated SS and (B) uncoated SS in the presence of blocking or isotype control antibodies.  #p 
< 0.002 α5 vs. isotype control, * p<0.05 αvβ3 vs. isotype control. 
 
Figure 4: FN7-10 coating enhances osteoblastic differentiation of hMSCs. (A) ALP activity at 9 
days. (B) Alizarin red staining for mineralization at 21 days. 
 
Figure 5: Mechanical fixation of SS screws to bone as determined by pull-out force in healthy 
rats at (A) 1 month and (B) 3 months post-implantation. Experimental values (n=4-5 per group) 
and mean ± std deviation are shown. 
 
Figure 6: Verification of osteoporotic state in ovariectomized rats. 3D µCT reconstructions of 
tibial metaphysis at 3 months after ovariectomy for (A) sham-operated and (B) ovariectomized 
(OVX) rats. C) Ratio of trabecular bone volume to total volume (BV/TV) 3 months after 
ovariectomy. 
 
Figure 7: Mechanical fixation of SS screws to bone as determined by pull-out force for (A) OVX 
and (B) sham-operated rats at 1 and 3 months post-implantation. Experimental values (n=5-8 per 
group for OVX, n=6-8 per group for sham-operated) and mean ± std deviation are shown.  
 
Figure 8: Bone-implant contact and bone ingrowth into screw threads. Histological sections 
stained with Sanderson’s Rapid Bone Stain and van Gieson counterstain  from osteoporotic rats 
at 3 months postimplantation in osteoporotic rats for  (A) FN7-10-coated and (B) uncoated SS 
screws. (C) Bone-implant contact and bone ingrowth into screw thread in osteoporotic rats after 
3 post-implantation.  
 








